Discussion in 'Research' started by StillTypeI, Sep 12, 2013.
Some good news.
It is good news, but I wish the study they are doing would target type-1 diabetes. It's targeting Alopecia Areata, which is a different autoimmune disease. There will be useful safety data in any case. I just wish someone would give Dr. Zhao a million for an American trial for type-1 diabetics. His research is worth more than that!
Separate names with a comma.